GlassScriptPhysician profile
Thomas M Dunn
NPI 1649258054
$1,428.49
in general payments reported to CMS, 2019-2025
12 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $91.84 · 2021: $334 · 2022: $529 · 2023: $21.64 · 2024: $35.70 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $434.91 | 2021-2022 | |
| Boston Scientific Corporation | $265.11 | 2020-2025 | General - Pain Management |
| Si-Bone, INC. | $200.56 | 2020-2025 | |
| Abbott Laboratories | $176.09 | 2019-2022 | |
| Nevro Corp. | $116.90 | 2021 | |
| Relievant Medsystems, INC. | $112.86 | 2021 | |
| Orthofix Medical, INC. | $30.19 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.26 | 2021 | |
| Nuvasive, INC. | $22.05 | 2020 | |
| Saluda Medical Americas, INC. | $21.64 | 2023 | Evoke Scs |
| Horizon Therapeutics Plc | $14.10 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.